MS patients may soon swap IV drips for a simple shot
NCT ID NCT07325292
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tests if a shot under the skin (subcutaneous) of the drug frexalimab works as well as the IV version for people with multiple sclerosis. About 160 adults aged 18-60 will receive either the shot or the IV every 4 weeks for 48 weeks. The goal is to see if the shot is a safe and effective option that is easier to take.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ANESC Research- Site Number : 8400187
RECRUITINGEl Paso, Texas, 79912, United States
-
Advanced Neurology of Colorado- Site Number : 8400148
RECRUITINGFort Collins, Colorado, 80528, United States
-
Alabama Neurology Associates- Site Number : 8400115
RECRUITINGHomewood, Alabama, 35209, United States
-
Aqualane Clinical Research- Site Number : 8400026
RECRUITINGNaples, Florida, 34105, United States
-
Hope Neurology- Site Number : 8400019
RECRUITINGKnoxville, Tennessee, 37922, United States
-
Investigational Site Number : 0560001
RECRUITINGBruges, 8000, Belgium
-
Investigational Site Number : 0560005
RECRUITINGOverpelt, 3900, Belgium
-
Investigational Site Number : 0560006
RECRUITINGGhent, 9000, Belgium
-
Investigational Site Number : 0560007
RECRUITINGKortrijk, 8500, Belgium
-
Investigational Site Number : 1560004
RECRUITINGChengdu, 610041, China
-
Investigational Site Number : 1560010
RECRUITINGJiazhuang, 050000, China
-
Investigational Site Number : 1561029
RECRUITINGChengdu, 610072, China
-
Investigational Site Number : 3920017
RECRUITINGSapporo, Hokkaido, 063-0005, Japan
-
Joi Life Wellness Group LLC- Site Number : 8400192
RECRUITINGSmyrna, Georgia, 30080, United States
-
Michigan Institute for Neurological Disorders- Site Number : 8400004
RECRUITINGFarmington Hills, Michigan, 48334, United States
-
Neurology Associates of Ormond Beach- Site Number : 8400086
RECRUITINGOrmond Beach, Florida, 32174, United States
-
Neurology of Central Florida- Site Number : 8400147
RECRUITINGAltamonte Springs, Florida, 32714, United States
-
North Central Neurology Associates- Site Number : 8401100
RECRUITINGCullman, Alabama, 35058, United States
-
North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083
RECRUITINGPlano, Texas, 75024, United States
-
Palm Beach Neurology- Site Number : 8400105
RECRUITINGWest Palm Beach, Florida, 33407, United States
-
Perseverance Research Center- Site Number : 8400138
RECRUITINGScottsdale, Arizona, 85253, United States
-
Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002
RECRUITINGCharlotte, North Carolina, 28210, United States
-
Private Practice - Dr. Regina Berkovich- Site Number : 8400005
RECRUITINGWest Hollywood, California, 90048, United States
-
Raleigh Neurology Associates- Site Number : 8400014
RECRUITINGRaleigh, North Carolina, 27607, United States
Conditions
Explore the condition pages connected to this study.